The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in

Siri Sjöberg1, Frida Sundh2, Todd Schlegel3

  • 1Department of Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Duke University, Durham, NC, USA.

Insights

Electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) are unreliable for assessing left ventricular mass (LVM) in transcatheter aortic valve replacement (TAVR) patients. QRS duration showed a moderate correlation with LVM.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Valvular Heart Disease

Background:

  • Calcific aortic stenosis (AS) is a prevalent condition in the elderly, often leading to left ventricular hypertrophy (LVH) and heart failure symptoms.
  • Transcatheter aortic valve replacement (TAVR) is a treatment for severe AS.
  • Previous research indicates poor correlation between electrocardiogram (ECG) criteria for LVH and echocardiographic left ventricular mass (LVM), but this has not been studied in TAVR patients.

Purpose of the Study:

  • To assess the diagnostic and quantitative accuracy of ECG LVH criteria for evaluating LVM in patients undergoing TAVR.

Main Methods:

  • Twenty-four TAVR patients without pacemakers or bundle branch block underwent pre-procedural ECG and echocardiography.
  • ECGs were analyzed using Sokolow-Lyon, Romhilt-Estes, and Cornell Voltage criteria for LVH, alongside spatial maximal QRS-T angle and 3D QRS maximal vector.
  • Left ventricular mass (LVM) was quantified via echocardiography.

Main Results:

  • 15 patients (63%) exhibited LVH by echocardiography.
  • ECG criteria positivity rates were: Sokolow-Lyon (29%), Romhilt-Estes (21%), and Cornell Voltage (50%).
  • No significant correlation was found between LVM and conventional ECG LVH criteria or spatial parameters. QRS duration demonstrated a moderate correlation with LVM (r=0.56, p=0.005).

Conclusions:

  • Conventional ECG criteria for LVH are not recommended for LVM evaluation in TAVR patients.
  • QRS duration is the most useful ECG parameter, showing a moderate correlation with LVM in this cohort.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...